New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
08:02 EDTABAXAbaxis receives Health Canada Class III approval for Piccolo Xpress
Abaxis announced Health Canada approved the Piccolo Xpress and Piccolo Reagent Discs as a Class III medical device for use throughout Canada. With this reclassification, Canadian healthcare providers and patients can now enjoy the benefits of lab-accurate blood chemistry diagnostics at the point-of-care.
News For ABAX From The Last 14 Days
Check below for free stories on ABAX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
09:34 EDTABAXAbaxis upgraded to Neutral from Underperform at BofA/Merrill
July 25, 2014
07:32 EDTABAXAmerican Veterinary Medical Association to hold a conference
Subscribe for More Information
July 24, 2014
16:19 EDTABAXAbaxis reports Q1 EPS 21c, consensus 19c
Subscribe for More Information
July 22, 2014
07:08 EDTABAXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use